|
Volumn 75, Issue 3, 2007, Pages 230-237
|
Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial
|
Author keywords
Dilation and evacuation; Mifepristone; Misoprostol; Second trimester abortion
|
Indexed keywords
CABERGOLINE;
DOXYCYCLINE;
METHYLERGOMETRINE;
MIFEPRISTONE;
MISOPROSTOL;
ADULT;
ARTICLE;
CHILL;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
FEMALE;
FEVER;
GESTATIONAL AGE;
HUMAN;
INDUCED ABORTION;
INFECTION;
MAJOR CLINICAL STUDY;
NAUSEA;
RANDOMIZED CONTROLLED TRIAL;
SECOND TRIMESTER ABORTION;
SINGLE DRUG DOSE;
SPAIN;
SPOTTING;
TREATMENT DURATION;
TREATMENT OUTCOME;
UTERINE CERVIX DILATATION;
VOMITING;
ABORTIFACIENT AGENTS;
ABORTION, INDUCED;
ADMINISTRATION, INTRAVAGINAL;
ADMINISTRATION, SUBLINGUAL;
DILATATION AND CURETTAGE;
FEMALE;
GESTATIONAL AGE;
HUMANS;
MIFEPRISTONE;
MISOPROSTOL;
PREGNANCY;
PREGNANCY TRIMESTER, FIRST;
PREGNANCY TRIMESTER, SECOND;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 33846877850
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/j.contraception.2006.11.007 Document Type: Article |
Times cited : (26)
|
References (14)
|